ArticleCancer medicine2019

Comparison  of  efficacy, safety, and costs between neoadjuvant hypofractionated radiotherapy and conventionally fractionated radiotherapy for esophageal carcinoma.

Jiahua Lyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.